How to Wean Off Vaping
Based on the most recent high-quality evidence, use varenicline as first-line pharmacotherapy combined with text message-based behavioral support to quit vaping 1, 2.
Pharmacological Approach
First-Line: Varenicline
- Varenicline doubles your chances of successfully quitting vaping (cessation rate 2x higher than placebo at 6 months) 1
- This is the strongest pharmacological evidence available, though based on limited data (140 participants in one study)
- Monitor for neuropsychiatric side effects (anxiety, depression, suicidal ideation) and seizure risk, though FDA has removed the black box warning 3
- Screen for seizure disorders before starting
Alternative Options (Weaker Evidence)
- Nicotine Replacement Therapy (NRT): Combination NRT (patch + short-acting form) showed no clear benefit over placebo in available studies 1, 4
- Cytisine: Insufficient evidence - no cessation data at 6+ months 1
- Note: The evidence for NRT in vaping cessation is much weaker than for traditional smoking cessation
Behavioral Interventions
First-Line: Text Message Programs
- Text message-based interventions increase quit rates by 32% in youth and young adults (ages 13-24) 1
- These programs work through:
- Daily motivational messages
- Coping strategies for cravings
- Peer support components
- Flexible, stepwise goal-setting 5
- More effective for vapers than traditional intensive counseling due to their engagement preferences 5
Nicotine Tapering Strategy
While evidence is limited, a structured taper may help 6:
- Gradually reduce nicotine concentration in your vape liquid over weeks
- Restrict vaping times (e.g., only during specific hours, then progressively fewer times per day)
- Combine with behavioral counseling for accountability
Critical Implementation Points
Age-Specific Considerations
- For adolescents (<18 years): The 2025 American Thoracic Society guideline acknowledges that nicotine use disorder in adolescents is difficult to treat 3. Text-based interventions are preferred given engagement patterns
- For adults: Varenicline + text messaging is the evidence-based combination
Common Pitfalls to Avoid
- Don't assume vaping is "easier to quit" than smoking - modern vapes deliver highly potent nicotine salts that may be more addictive 7
- Monitor for dual use - continuing to vape while trying to quit increases health risks beyond either product alone 7
- Watch for psychiatric symptoms during withdrawal - nicotine withdrawal itself can worsen anxiety and depression 3
- Screen medication interactions - review all medications and supplements before starting varenicline or bupropion 3
What NOT to Do
- Avoid relying solely on willpower - structured interventions significantly improve success rates 2
- Don't use traditional smoking cessation counseling approaches - vapers respond better to digital, gamified, peer-based strategies than traditional intensive face-to-face counseling 5
Monitoring and Follow-Up
- Assess withdrawal symptoms weekly for first month
- Screen for return to combustible cigarette smoking (a common unintended consequence)
- Continue behavioral support for at least 6 months - most relapses occur early 1
- Zero serious adverse events were reported in most vaping cessation studies, but remain vigilant for psychiatric effects with varenicline 1
Evidence Quality Note
The overall evidence base remains limited - most studies have small sample sizes and short follow-up periods 4, 2. However, the combination of varenicline plus text messaging represents the best available evidence-based approach, with 14 ongoing trials that will strengthen recommendations in coming years 1, 4.